Title: Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study
Authors: Matthaei, Stephan ×
Reaney, Matthew
Mathieu, Chantal
Ostenson, Claes-Göran
Krarup, Thure
Guerci, Bruno
Kiljanski, Jacek
Petto, Helmut
Bruhn, David
Theodorakis, Michael #
Issue Date: Nov-2012
Publisher: Springer Healthcare Ltd.
Series Title: Diabetes Therapy vol:3 issue:1 pages:6
Abstract: Changes to Treatment and Outcomes in Patients with Type 2 Diabetes Initiating Injectable Therapy (CHOICE) is a European prospective, observational cohort study assessing time to, and factors associated with, a significant change in therapy after type 2 diabetes patients initiate their first injectable glucose-lowering therapy, and these patients' clinical outcomes over 24 months. The authors report baseline data and factors associated with the injectable treatment regimen.
ISSN: 1869-6961
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Clinical and Experimental Endocrinology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.